- Home
- ATAI vs ISPR Comparison
ATAI vs ISPR Comparison
Compare ATAI & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATAI | ISPR |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 161.5M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ATAI | ISPR |
|---|---|---|
| Price | $4.00 | $2.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $14.33 | $7.50 |
| AVG Volume (30 Days) | ★ 3.4M | 34.7K |
| Earning Date | 11-12-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,018,000.00 | ★ $118,506,875.00 |
| Revenue This Year | $943.18 | $11.60 |
| Revenue Next Year | N/A | $40.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 811.78 | N/A |
| 52 Week Low | $1.15 | $1.44 |
| 52 Week High | $6.75 | $5.12 |
Technical Indicators
Market Signals| Indicator | ATAI | ISPR |
|---|---|---|
| Relative Strength Index (RSI) | 45.43 | 48.12 |
| Support Level | $3.64 | $2.57 |
| Resistance Level | $4.14 | $2.93 |
| Average True Range (ATR) | 0.25 | 0.20 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 32.87 | 30.51 |
Price Performance
Historical ComparisonAbout ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.